kongre.net
Welcome to kongre.net

Speaker

Mark Bach

Chief Medical Officer, GentiBio

Mark Bach, Chief Medical Officer at GentiBio, is speaking at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Early-Phase Clinical Evaluation of GNTI-122, an Engineered Regulatory T-Cell Therapy, in Recent- Onset Type 1 Diabetes”.

Conferences
1
Keynotes
0
Upcoming
1

Upcoming appearances

More speakers at 4th Cell Therapy for Autoimmune Disease Summit 2026

  • Fred Aslan

    President & Chief Executive Officer, Artiva Biotherapeutics, Inc

  • Rena Baek

    Executive Director, Preclinical Development, Moderna

  • Michael Mingueneau

    Vice President, Immunology, Sail Biomedicines

  • Daniel Shelly

    Chief Business Development Officer, PolTREG

  • Edward Zhang

    Co-Founder & Chief Executive Officer, Overland Therapeutics

  • Nathalie Belmonte

    Chief Science & Technical Officer, Quell Therapeutics

See all 22 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mark Bach, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].